Tetsuya Ikemoto Selected Research

Biological Products

7/2018	Role of heat shock factor 1 expression in the microenvironment of intrahepatic cholangiocarcinomas.
1/2017	Pathophysiology of recurrent hepatocellular carcinoma after radiofrequency ablation.
9/2011	Hypoxia inducible factor expression in intrahepatic cholangiocarcinoma.
2/2010	Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuya Ikemoto Research Topics

Disease

67	Neoplasms (Cancer) 04/2022 - 01/2005
24	Hepatocellular Carcinoma (Hepatoma) 06/2022 - 02/2005
15	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2006
14	Cholangiocarcinoma 01/2022 - 08/2010
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 04/2007
8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2009
6	Carcinogenesis 09/2014 - 02/2011
5	Hypoxia (Hypoxemia) 01/2017 - 09/2011
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2014
4	Lymphatic Metastasis 03/2021 - 05/2011
4	Colonic Neoplasms (Colon Cancer) 12/2020 - 01/2016
4	Ischemia 05/2018 - 03/2013
4	Carcinoma (Carcinomatosis) 11/2017 - 09/2010
4	Body Weight (Weight, Body) 07/2015 - 01/2011
3	Frailty 09/2021 - 01/2021
3	Stomach Neoplasms (Stomach Cancer) 01/2021 - 03/2006
3	Liver Diseases (Liver Disease) 10/2018 - 01/2014
3	Liver Cirrhosis (Hepatic Cirrhosis) 03/2016 - 09/2010
3	Hemorrhage 01/2012 - 09/2008
2	Liver Neoplasms (Liver Cancer) 04/2022 - 09/2014
2	Non-alcoholic Fatty Liver Disease 03/2022 - 12/2014
2	Rectal Neoplasms (Rectal Cancer) 01/2021 - 01/2005
2	Hypoglycemia (Reactive Hypoglycemia) 09/2020 - 01/2014
2	Liver Failure 01/2019 - 09/2007
2	Reperfusion Injury 12/2014 - 01/2014
2	Pancreaticobiliary Maljunction 05/2014 - 01/2013
2	Aneurysm (Aneurysms) 08/2013 - 01/2013
2	Vomiting 01/2012 - 05/2011
2	Fibrosis (Cirrhosis) 09/2011 - 03/2008
2	Diabetes Mellitus 01/2010 - 08/2004
1	Alcoholic Fatty Liver 03/2022
1	Metabolic Diseases (Metabolic Disease) 09/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2021
1	Lymphoma (Lymphomas) 05/2021
1	B-Cell Leukemia (Leukemia, B Cell) 05/2021
1	Obstructive Jaundice (Cholestatic Jaundice) 12/2020

Drug/Important Bio-Agent (IBA)

11	Messenger RNA (mRNA)IBA 04/2022 - 04/2007
8	Proteins (Proteins, Gene)FDA Link 05/2021 - 12/2014
7	MicroRNAs (MicroRNA)IBA 01/2022 - 06/2014
7	Indicators and Reagents (Reagents)IBA 12/2021 - 08/2010
6	Conditioned Culture MediaIBA 04/2022 - 08/2018
6	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 02/2011
6	Fluorouracil (Carac)FDA LinkGeneric 11/2017 - 01/2005
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2017
5	Interleukin-6 (Interleukin 6)IBA 12/2020 - 11/2014
5	Peptides (Polypeptides)IBA 01/2017 - 01/2014
4	Insulin (Novolin)FDA Link 10/2020 - 09/2014
4	Histone Deacetylase InhibitorsIBA 01/2020 - 02/2011
4	Valproic Acid (Depakote)FDA LinkGeneric 01/2020 - 12/2011
4	Biological ProductsIBA 07/2018 - 02/2010
4	Gemcitabine FDA Link 11/2017 - 11/2011
4	EnzymesIBA 01/2014 - 04/2007
4	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 06/2012 - 04/2007
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022 - 06/2014
3	CytokinesIBA 04/2022 - 11/2014
3	AlbuminsIBA 01/2021 - 02/2018
3	Blood Glucose (Blood Sugar)IBA 09/2020 - 01/2011
3	Cadherins (E-Cadherin)IBA 02/2020 - 09/2016
3	InterferonsIBA 07/2014 - 12/2011
3	Thymidylate SynthaseIBA 06/2012 - 01/2011
2	C-Reactive ProteinIBA 12/2021 - 01/2021
2	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 01/2018
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2021 - 01/2016
2	acarboxyprothrombin (PIVKA)IBA 01/2021 - 12/2014
2	Bevacizumab (Avastin)FDA Link 09/2019 - 04/2014
2	Pentetic Acid (DTPA)FDA LinkGeneric 01/2019 - 07/2012
2	VimentinIBA 08/2018 - 05/2016
2	BilirubinIBA 02/2018 - 03/2016
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 09/2011
2	Cisplatin (Platino)FDA LinkGeneric 11/2017 - 03/2008
2	HLA-A Antigens (HLA-A)IBA 01/2017 - 01/2017
2	Protein Subunit VaccinesIBA 01/2017 - 01/2017
2	CateninsIBA 07/2016 - 02/2016
2	Epithelial Cell Adhesion MoleculeIBA 05/2016 - 06/2014
2	phytobacteriomycin (PBM)IBA 05/2014 - 01/2013
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 04/2014 - 10/2012
2	juzentaihotoIBA 02/2014 - 01/2011
1	X-Box Binding Protein 1IBA 03/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 08/2021
1	fibrin fragment D (D-dimer)IBA 06/2021
1	somatostatin receptor 2IBA 05/2021
1	Serum AlbuminIBA 03/2021
1	OsteopontinIBA 02/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	Beclin-1IBA 12/2020

Therapy/Procedure

29	Hepatectomy 06/2022 - 02/2008
12	Therapeutics 01/2018 - 01/2005
9	Liver Transplantation 10/2018 - 02/2005
8	Drug Therapy (Chemotherapy) 12/2021 - 05/2011
4	Transplantation 10/2018 - 08/2004
3	Radiofrequency Ablation 01/2017 - 06/2014
3	Gastrectomy 01/2017 - 03/2006
3	Splenectomy 03/2016 - 09/2010
3	Islets of Langerhans Transplantation 01/2012 - 01/2010
2	Lymph Node Excision (Lymph Node Dissection) 01/2012 - 01/2005
2	Organ Transplantation 09/2011 - 01/2009
1	Autologous Transplantation 01/2022
1	Cell Transplantation 09/2021
1	Chemoradiotherapy 01/2021